Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding Ltd.
Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics

Roche Holding AG operates as a research healthcare company.

It operates through the following segments: Diagnostics and Pharmaceuticals.

The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.

The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process.

The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Number of employees : 94 052 persons.
Sales per Businesses
20152016Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals39,45081.9%41,04781.2% +4.05%
Diagnostics10,95322.8%11,58922.9% +5.81%
Sales per Regions
20152016Delta
CHF (in Million)%CHF (in Million)%
United States22,18846.1%22,95945.4% +3.47%
Rest of Europe10,05020.9%10,26720.3% +2.16%
Rest of Asia6,01512.5%6,47112.8% +7.58%
Japan3,6797.6%4,2438.4% +15.33%
Latin America2,8325.9%2,6815.3% -5.33%
Germany2,7585.7%3,0326% +9.93%
Africa, Australia and Oceania1,3632.8%1,3352.6% -2.05%
Rest of North America856.001.8%852.001.7% -0.47%
Switzerland662.001.4%796.001.6% +20.24%
Managers
NameAgeSinceTitle
Severin Schwan512008Chief Executive Officer & Executive Director
Christoph Franz582011Chairman
Alan Hippe, PhD512011Chief Financial & Information Technology Officer
John Irving Bell, MD662001Non-Executive Director
Andreas Oeri, MD691996Independent Non-Executive Director
Paul Bulcke642011Non-Executive Director
Peter R. Voser592011Non-Executive Director
André S. Hoffmann, MBA591996Vice Chairman
Bernard J. Poussot662015Non-Executive Director
Richard P. Lifton MD, PhD602015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 702,562,700 693,297,592 98.7% 9,265,108 1.3% 83.5%
Share B 1 160,000,000 26,557,237 16.6% 0 0.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 17,949,531 2.55%
Norges Bank Investment Management 17,167,261 2.44%
UBS AG (Investment Management) 11,856,934 1.69%
Roche Holding AG 9,200,000 1.31%
PRIMECAP Management Co. 8,796,799 1.25%
Wellington Management Co. LLP 8,613,951 1.23%
BlackRock Fund Advisors 8,518,031 1.21%
Credit Suisse Asset Management (Schweiz) AG 6,183,400 0.88%
Massachusetts Financial Services Co. 5,892,083 0.84%
Alecta Pension Insurance Mutual 5,843,000 0.83%
Holdings
NameEquities%Valuation
Chugai Pharmaceutical Co Ltd (4519) 335,223,00059.9%17,170,323,194 USD
Roche Holding Ltd. (ROG) 9,200,0001.31%2,327,142,116 USD
Foundation Medicine Inc (FMI) 21,019,11158.0%1,433,503,370 USD
Ignyta Inc (RXDX) 4,324,2356.40%115,457,075 USD
Senseonics Holdings Inc (SENS) 28,345,27621.0%75,398,434 USD
Curetis (CURE) 966,4896.22%4,578,413 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : www.roche.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-5.40%210 743
JOHNSON & JOHNSON5.20%394 704
NOVARTIS0.61%224 711
PFIZER2.65%220 487
MERCK AND COMPANY10.24%166 723
AMGEN8.11%136 174
SANOFI0.72%112 074
NOVO NORDISK A/S2.24%110 515
BAYER-0.50%104 914
ABBOTT LABORATORIES3.36%102 817
BRISTOL-MYERS SQUIBB COMPANY0.93%101 197
ELI LILLY AND COMPANY0.98%94 496
GLAXOSMITHKLINE2.32%93 292
ASTRAZENECA-2.74%87 603
CELGENE CORPORATION-2.24%80 086
ALLERGAN PLC8.03%59 745
TAKEDA PHARMACEUTICAL CO LTD-1.20%45 825
SHIRE-11.47%43 632
JIANGSU HENGRUI MEDICINE CO LTD5.54%32 088
CHUGAI PHARMACEUTICAL CO LTD0.17%29 183
ASTELLAS PHARMA INC-4.14%25 941
Connections : Roche Holding Ltd.
Fondation Jan Michalski Pour L'écriture Et La Littérature
Givaudan Foundation
International Business Leaders Advisory Council
Swiss-American Chamber of Commerce
International Federation of Pharmaceutical Manufacturers A
Fondation Tour du Valat
International Committee of the Red Cross
The Rockefeller University
Credit Suisse AG
Fondation Pro Valat
Zurich Insurance Co. Ltd.
Stadler Rail AG
Fondation Auxiliaire du Conservatoire botanique de la Ville de
Eisenhower Fellowships, Inc.
Ernst Göhner Foundation
European Round Table of Industrialists
Zurich Insurance Group Ltd.
Fondation Hoffmann
Lucerne Festival
Fondation MAVA
Voith GmbH
Inovalon, Inc.
The Oxford Health Alliance
WWF International
GMEC Management Co. Ltd.
Fondation Dr Henri Dubois-Ferrière Dinu Lipatti
Office for Strategic Co-ordination of Health Research
Weidenfeld Hoffmann Trust
Oxford Sciences Innovation Plc
Tate Gallery Foundation, Inc.
Immunocore Ltd.
Fort Dodge Animal Health, Inc.
Oxagen Ltd.
New York Genome Center
Oxford University Hospitals NHS Trust
Catalyst, Inc.
The Gray Laboratory Cancer Research Trust
Peter G. Peterson Institute for International Economics
Rhodes Trust
Fondation pour l’art musical, lyrique et chorégraphique
The Ewelme Almshouse Charity
Fondation Internationale du Banc d'Arguin
Genomics England Ltd.
Institute For Strategic Dialogue
Oxford Centre for Diabetes Endocrinology & Metabolism
The Jenner Institute
Amazentis SA
Credit Suisse (Schweiz) AG
Glyndebourne Productions Ltd.
Cereal Partners Worldwide SA
Fondation les Corbillettes
Peace Parks Foundation
Nestlé Health Science SA
Paul Sacher Stiftung
Nestlé Skin Health SA
Fondation Prince Albert II of Monaco
L'Oréal USA, Inc.
Systemiq Ltd.
University of Oxford
IMD Scholarship Foundation
Max Planck Florida Institute for Neuroscience
Cargill, Inc.
St. Gallen Foundation for International Studies
ESCP Europe Campus Paris
Roche Holdings, Inc.
The Rockefeller Archive Center
Temasek Holdings (Pte) Ltd.
Yale School of Medicine
© 2018 People , Fundamentals and Ownership